Fig. 1: Palantir characterizes cell fate choices in a continuous model of differentiation. | Nature Biotechnology

Fig. 1: Palantir characterizes cell fate choices in a continuous model of differentiation.

From: Characterization of cell fate probabilities in single-cell data with Palantir

Fig. 1

a, Top: Projection of CD34+ human bone marrow cells along diffusion components. Bottom: Expression of gene pairs involved in lineage decisions for cells in the corresponding top panel. Cells colored by Phenograph cluster (Supplementary Fig. 4a); arrows highlight continuity in cell fate choices as a pervasive lack of well-defined branch points in decision-making regions. Plots show comparison of 3,170, 4,224, and 3,510 cells, respectively. bd, Palantir phenotypic manifold for a subsampled dataset of CD34+ human hematopoiesis. Each dot represents a cell embedded into diffusion space based on the first three components and visualized using tSNE. b, Cartoon of Markov chain construction over the manifold. Cells colored by pseudo-time. c, Cells colored by the stationary distribution of the Markov chain in b, demonstrating outliers (yellow) in the mature states. Outliers that are also boundary states (circles) are selected as terminal states. d, Cells colored by differentiation potential (DP). Highlighted examples (circles) show relationship between pseudo-time, DP, and branch probabilities (histogram with bars colored by terminal state or branch, Br). High DP (1) decreases gradually as cells move toward commitment (2 and 3). Modeling cell fate choices as probabilities provides a representation of their continuity (4–7). e, Expression of a branch A-specific gene along pseudo-time. Left: Each dot represents a cell colored by its probability of reaching terminus A. Black line, gene expression trend for this data. Right. Expression trends for the three lineages. The unified framework of pseudo-time and branch probabilities enables gene expression dynamics to be characterized across a common axis. DC, dendritic cells; Ery, erythroid cells; Mega, megakaryocytes; Mono, monocytes; Myl, myeloid cells.

Back to article page